{"id":390870,"date":"2017-10-31T00:00:00","date_gmt":"2017-10-31T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/cutrmd0016-2017-biopharma-type-2-diabetes-current-treatment-eu5-2017\/"},"modified":"2026-05-07T05:24:07","modified_gmt":"2026-05-07T05:24:07","slug":"cutrmd0016-2017-biopharma-type-2-diabetes-current-treatment-eu5-2017","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/cutrmd0016-2017-biopharma-type-2-diabetes-current-treatment-eu5-2017\/","title":{"rendered":"Type 2 Diabetes | Current Treatment | EU5 | 2017"},"content":{"rendered":"<p>The type 2 diabetes market is expanding rapidly, fueled by increasing prevalence and a wave of recent product launches. Sanofi\u2019s Suliqua (lixisenatide\/insulin glargine), Novo Nordisk\u2019s Fiasp, and AstraZeneca\u2019s Glyxambi (linagliptin\/empagliflozin) are examples of recent European product approvals. DRG believes the positive results from the EMPA-REGCVOT for Boehringer Ingelheim\u2019s\/Eli Lilly\u2019s Jardiance will benefit uptake of the entire\u00a0SGLT-2 inhibitor class. Current Treatment explores how the prescribing behaviors of European endocrinologists have changed in response to the rise of the SGLT-2 inhibitors and how other novel drugs compare.<\/p>\n","protected":false},"template":"","class_list":["post-390870","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-type-1-diabetes","biopharma-therapy-areas-type-2-diabetes","biopharma-product-current-treatment","biopharma-date-890"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390870\/revisions"}],"predecessor-version":[{"id":393994,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390870\/revisions\/393994"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=390870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}